CLINICAL_TRIALS trial_result · 2023-04-04

Clinical Trial Update: Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer [Phase 2]

Phase 2 trial evaluating re-induction with immune therapy plus radiotherapy in stage IV non-small cell lung cancer after initial response.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Maastricht Radiation Oncology | Conditions: Non-Small Cell Carcinoma of Lung, TNM Stage 4 | Phase 2 | Status: COMPLETED